Cellular therapy for autism spectrum disorder: a step forward to the optimal treatments
- PMID: 31576317
- PMCID: PMC6685839
- DOI: 10.21037/atm.2019.05.12
Cellular therapy for autism spectrum disorder: a step forward to the optimal treatments
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Comment on
-
White Matter Tract Changes Associated with Clinical Improvement in an Open-Label Trial Assessing Autologous Umbilical Cord Blood for Treatment of Young Children with Autism.Stem Cells Transl Med. 2019 Feb;8(2):138-147. doi: 10.1002/sctm.18-0251. Epub 2019 Jan 8. Stem Cells Transl Med. 2019. PMID: 30620122 Free PMC article. Clinical Trial.
References
-
- Siniscalco D, Mijatovic T, Bosmans E, et al. Decreased Numbers of CD57+CD3- Cells Identify Potential Innate Immune Differences in Patients with Autism Spectrum Disorder. In Vivo 2016;30:83-9. - PubMed
Publication types
LinkOut - more resources
Full Text Sources